The discussion examines which patients, particularly those with type 2 diabetes and cardiovascular risk, may benefit most, along with key limitations such as its exploratory design and gastrointestinal tolerability
The study did not break down results by specific medication, so we cannot determine whether tirzepatide users experienced more or less improvement than semaglutide users
*Disclaimer: Mounjaro is a registered trademark of Eli Lilly
As a GLP-1, semaglutide drugs like Ozempic and Wegovy work by : Slowing down how quickly food leaves your stomach Regulating your appetite by sending signals of satiety (fullness) to your brain Encouraging your pancreas to release more insulin after you eat Reducing the amount of glucose produced by your liver Together, these effects help you feel full longer, reduce cravings, and keep your blood sugar levels in check
Some users supplement strategically, and the guide to supplements to take with tirzepatide covers the most evidence-based options for supporting health during treatment
Reported semaglutide overdose adverse events include gastrointestinal effects (e.g., nausea, vomiting, abdominal pain), fainting, headache, migraine, dehydration, acute pancreatitis and gallstones